Read more
The Future of Pharmaceuticals: A Nonlinear Analysis provides an opportunity to understand the non-linearity of biological systems and its application in various areas of science, primarily pharmaceutical sciences. This book will benefit professionals in pharmaceutical industries, academia, and policy.
List of contents
Preface.....................................................................................................................................................xix
Acknowledgments.................................................................................................................................xxvii
Author....................................................................................................................................................xxix
Glossary of Important Terminology......................................................................................................xxxi
1 Understanding Nonlinearity............................................................................................................ 1
2 The Evolution of Pharmaceuticals................................................................................................. 23
3 Artificial Intelligence...................................................................................................................... 69
4 Drug Discovery Trends................................................................................................................... 91
5 Drug Development Assays.............................................................................................................143
6 Nanomedicine................................................................................................................................ 195
7 Antimicrobials................................................................................................................................231
8 Therapeutic Proteins......................................................................................................................251
9 Manufacturing Trends................................................................................................................. 307
10 Therapeutic Protein Delivery Systems........................................................................................ 345
11 Gene and Cell Therapy..................................................................................................................381
12 Nucleic Acid Vaccines....................................................................................................................421
13 Botanical Products........................................................................................................................ 439
14 Regulatory Optimization.............................................................................................................. 469
15 Intellectual Property......................................................................................................................531
Index........................................................................................................................................................557
About the author
Sarfaraz K. Niazi, Ph.D., is an Adjunct Professor at the University of Illinois and University of
Houston; he has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the field
of bioprocessing, drug discovery, mRNA vaccines, drug formulations, thermodynamic systems, alcohol
aging, nutraceuticals and treatment of autoimmune diseases. He has established multiple biotechnology
projects, from concept to market. He also serves as an advisor to major pharmaceutical and biopharmaceutical
companies, regulatory agencies, the FDA, the US Congress, and several heads of state. He is
also a patent law practitioner.
Summary
The Future of Pharmaceuticals: A Nonlinear Analysis provides an opportunity to understand the non-linearity of biological systems and its application in various areas of science, primarily pharmaceutical sciences. This book will benefit professionals in pharmaceutical industries, academia, and policy.
